Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma
Vox Sanguinis · 2024
DOI: 10.1111/vox.13709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Akihiro Fuchizaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Japanese Red Cross Kinki Block Blood Center, Osaka, Japan. Hauptthemen laut MEDLINE: Hemostasis, Blood Coagulation Factors, Lab-On-A-Chip Devices. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Quantifying the contribution of individual coagulation factors to haemostasis may aid our understanding of the haemostatic function in patients with rare coagulation deficiencies (RCDs) and the exploration of suitable treatments. Materials and Methods Reconstituted blood prepared from specific coagulation factor‐deficient plasma (factor [F]II; prothrombin, FV, FVII, FVIII, FIX, FX, FXI or FXII) and red blood cell/platelet products were used to simulate the whole blood of patients with RCD. We prepared in vitro treatment models for patients with prothrombin deficiency using coagulation factor agents and fresh frozen plasma. Haemostatic function was measured using a microchip flow chamber system at 600 s −1 .
Results
The haemostatic function was low, especially in blood samples reconstituted with prothrombin‐ and FX‐deficient plasma. In a plasma transfusion model of prothrombin deficiency, haemostatic function recovered after 10% replacement with normal plasma and reached a plateau at ≧60% replacement. A treatment model of prothrombin deficiency with prothrombin complex concentrates revealed dose‐dependent therapeutic effects in the range of 0–50 IU/kg.
Conclusion
Microchip flow chamber system‐based quantification of haemostatic function using reconstituted blood could predict haemostasis and therapeutic effects of treatments in patients with prothrombin deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
- Fujimori Kogyo Kabushiki Kaisha Kenkyujo, Yokohama, Japan.
- Japanese Red Cross Osaka Blood Center, Osaka, Japan.
ORCID-Profile: Akihiro Fuchizaki, Kazuta Yasui, Tomoya Hayashi, Yoshihiro Fujimura, Fumiya Hirayama
Zitieren
APA
Fuchizaki, A., Yasui, K., Hayashi, T., Fujimura, Y., Oyamada, C., Ohnishi-Wada, T., Hosokawa, K., Shimogaki, K., Kimura, T., Hirayama, F., & Takihara, Y. (2024). Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma. Vox Sanguinis. https://doi.org/10.1111/vox.13709
Vancouver
Fuchizaki A, Yasui K, Hayashi T, Fujimura Y, Oyamada C, Ohnishi-Wada T, et al. Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma. Vox Sanguinis. 2024. doi:10.1111/vox.13709
BibTeX
@article{Fuchizaki2024,
author = {Fuchizaki, Akihiro and Yasui, Kazuta and Hayashi, Tomoya and Fujimura, Yoshihiro and Oyamada, Chiaki and Ohnishi-Wada, Tomoko and Hosokawa, Kazuya and Shimogaki, Kazushige and Kimura, Takafumi and Hirayama, Fumiya and Takihara, Yoshihiro},
title = {Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma},
journal = {Vox Sanguinis},
year = {2024},
doi = {10.1111/vox.13709}
}
EUVIMED